<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03434197</url>
  </required_header>
  <id_info>
    <org_study_id>TPJ.01.2017</org_study_id>
    <nct_id>NCT03434197</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of SFPP in Knee Osteoarthritis</brief_title>
  <official_title>Randomized Controlled Study to Evaluate the Safety and Efficacy of SFPP in Knee Osteoarthritis Using Diclofenac Gel as the Comparator</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taisho Pharmaceutical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taisho Pharmaceutical Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are to demonstrate the non-inferiority of esflurbiprofen plaster
      (SFPP) 40 mg applied for 2 weeks to diclofenac gel, the comparator, in terms of efficacy in
      patients with knee osteoarthritis (OA) and to examine the safety of SFPP.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 5, 2018</start_date>
  <completion_date type="Anticipated">September 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of Knee pain on rising from the chair</measure>
    <time_frame>5 weeks (3 weeks of observation period and follow up with 2 weeks treatment period)</time_frame>
    <description>0-100 mm Visual Analogue Scale (VAS) (0mm, no pain; 100mm, worst pain ever)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement of Changes in total clinical symptom</measure>
    <time_frame>5 weeks (3 weeks of observation period and follow up with 2 weeks treatment period)</time_frame>
    <description>Assessment from investigator ( 0=Absent, 1=Mild, 2=Moderate, 3=Severe; total= 0 - 45 )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of Investigator's global assessment</measure>
    <time_frame>Last visit</time_frame>
    <description>Investigator's global assessment Questionnaire ( 1=Marked, 2=Moderate, 3=Mild, 4=No change, 5=Worse)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of Patient's global assessment</measure>
    <time_frame>Last visit</time_frame>
    <description>Patient's global assessment Questionnaire ( 1=Marked, 2=Moderate, 3=Mild, 4=No change, 5=Worse )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of Knee pain on walking</measure>
    <time_frame>5 weeks (3 weeks of observation period and follow up with 2 weeks treatment period)</time_frame>
    <description>0-100 mm Visual Analogue Scale (VAS) (0mm, no pain; 100mm, worst pain ever)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Rescue drug use during treatment period</measure>
    <time_frame>3 weeks (1 weeks of observation period and follow up with 2 weeks treatment period)</time_frame>
    <description>Report from investigator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Adverse events and adverse drug reactions</measure>
    <time_frame>5 weeks (3 weeks of observation period and follow up with 2 weeks treatment period)</time_frame>
    <description>Report from investigator</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">312</enrollment>
  <condition>Osteoarthritis Knee Pain</condition>
  <arm_group>
    <arm_group_label>SFPP (Esflurbiprofen plaster)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A plaster containing 40 mg of Esflurbiprofen and 36.2 mg of Japanese Pharmacopoeia mentha oil per patch (10 × 14 cm)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diclofenac gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A gel containing 11.6 mg of Diclofenac diethylamine (equivalent to 10 mg of diclofenac sodium) per 1 g (1 tube contains 20 g)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Esflurbiprofen</intervention_name>
    <description>A plaster containing 40 mg of Esflurbiprofen and 36.2 mg of Japanese Pharmacopoeia mentha oil per patch (10 × 14 cm)</description>
    <arm_group_label>SFPP (Esflurbiprofen plaster)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac diethylamine</intervention_name>
    <description>A gel containing 11.6 mg of Diclofenac diethylamine (equivalent to 10 mg of diclofenac sodium) per 1 g (1 tube contains 20 g)</description>
    <arm_group_label>Diclofenac gel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who had unilateral knee pain and were classified as Grade II or III according
             to Kellgren-Lawrence (KL) grading and whose non-assessed knee is not graded higher
             than the assessed knee based on x-ray in standing, weight-bearing extension position
             within 90 days before screening visit (1st visit)

          -  Patients whose knee pain on rising from the chair assessed by visual analogue scale
             (rVAS) of the assessed knee meets all the following criteria for the level of pain; &lt;
             80 mm at washout visit (2nd visit), ≥ 40 mm at baseline visit (3rd visit), Worsening
             of ≥ 15 mm at baseline visit (3rd visit) compared with rVAS at washout visit (2nd
             visit) as a result of discontinuation of use of NSAIDs

        Exclusion Criteria:

          -  Patients with complication of rheumatoid arthritis, history of knee surgery, malignant
             tumor, neuropsychiatric disease, or serious disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bambang Setyohadi, Dr. Sp.PD-KR</last_name>
    <role>Study Chair</role>
    <affiliation>Rumah Sakit Cipto Mangunkusumo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sumariyono, Dr. Sp.PD-KR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rumah Sakit Cipto Mangunkusumo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tanggo Meriza, Dr. Sp.PD-KR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rumah Sakit Islam Pd. Kopi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sandra Sinthya Langow, Dr. Sp.PD-KR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rumah Sakit Siloam Karawaci</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ika Wulan Yuliani, Dr. Sp.PD-KR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rumah Sakit Anna Medika Bekasi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rachmat Gunadi Wachjudi, Dr. Sp.PD-KR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rumah Sakit Hasan Sadikin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andri Reza, Dr. Sp.PD-KR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rumah Sakit Umum Daerah Al Ihsan Bale Endah</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laniyati Hamijoyo, Dr. Sp.PD-KR</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinik Perisai Husada</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Masahiro Tagawa</last_name>
    <phone>+819032164464</phone>
    <email>m-tagawa@taisho.co.jp</email>
  </overall_contact>
  <location>
    <facility>
      <name>Klinik Perisai Husada</name>
      <address>
        <city>Bandung</city>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laniyati Hamijoyo, Dr. Sp.PD-KR</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rumah Sakit Hasan Sadikin</name>
      <address>
        <city>Bandung</city>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachmat Gunadi Wachjudi, Dr. Sp.PD-KR</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rumah Sakit Umum Daerah Al Ihsan Bale Endah</name>
      <address>
        <city>Bandung</city>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andri Reza, Dr. Sp.PD-KR</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rumah Sakit Anna Medika Bekasi</name>
      <address>
        <city>Jakarta</city>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ika Wulan Yuliani, Dr. Sp.PD-KR</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rumah Sakit Islam Pd. Kopi</name>
      <address>
        <city>Jakarta</city>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tanggo Meriza, Dr. Sp.PD-KR</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rumah Sakit Siloam Karawaci</name>
      <address>
        <city>Jakarta</city>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Sinthya Langow, Dr. Sp.PD-KR</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 2, 2018</study_first_submitted>
  <study_first_submitted_qc>February 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2018</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Osteoarthritis Knee Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

